
Image: Deutsche Welle
Updated
A US judge in Missouri approved Bayer's $7.25 billion settlement on Friday, resolving lawsuits that claim its Roundup weedkiller causes non-Hodgkin lymphoma, a blood cancer. Deutsche Welle reported that the deal covers tens of thousands of people who say they developed the disease after using Roundup, as well as people who may be diagnosed later after past exposure. Bayer will pay up to $7.25 billion into a fund over 21 years, with individual payments expected to average between $10,000 and $165,000 depending on age, illness severity and length of exposure. Some lawyers for cancer patients have called the payments too low, but Judge Timothy Boyer rejected their objections, saying further delays could leave seriously ill patients waiting years. Christopher Seeger, a lawyer for cancer patients, welcomed the ruling, and Bayer CEO Bill Anderson called it a decisive milestone. The ruling could still be appealed. Deutsche Welle also reported that the settlement follows a June US Supreme Court ruling that Bayer could not be sued under state laws over cancer warnings on Roundup packaging, and that about 200 other cases remain in federal courts.